Ambrx pulls in $200m
California-based Ambrx Inc, a clinical-stage biopharmaceutical company, has raised $200 million in financing.
California-based Ambrx Inc, a clinical-stage biopharmaceutical company, has raised $200 million in financing.
Copyright PEI Media
Not for publication, email or dissemination